Administrative Core
行政核心
基本信息
- 批准号:10469703
- 负责人:
- 金额:$ 8.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-18 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAdvocateAnimalsAwardCase ManagementCommunicationCommunitiesCommunity MedicineComprehensive Cancer CenterCore FacilityDevelopmentEnsureEvaluationFacultyFundingGrantHuman ExperimentationInfrastructureIntellectual PropertyInterventionKnowledgeLeadershipLinkMonitorPathologyPatient advocacyPatientsPerformancePreventionPrincipal InvestigatorRegulationReportingResearchResearch PersonnelResearch Project GrantsResource SharingRiskSafetySpecialized Program of Research ExcellenceStrategic PlanningTrainingVisitWorkcancer health disparitydisparity eliminationexperiencehealth equitymedical schoolsmeetingsorganizational structureprogramssuccess
项目摘要
PROJECT SUMMARY/ABSTRACT
The Administrative Core, will provide for overall direction, coordination, and administration of the Case Cancer
Disparities SPORE P20. The Administrative Core will include: the P20 Multiple Principal Investigators (Core Co-
Directors), and the P20 Administrative Coordinator. The Administrative Core will oversee the functioning of: the
P20 Executive Committee, the P20 Internal Advisory Board, the P20 External Advisory Board, the P20
Community Advisory Board, and the P20 Patient Advocacy Board. It will be responsible for facilitating,
coordinating, stimulating, monitoring and maintaining scientific and financial oversight for all P20 activities. It will
provide the central forum for interaction among all P20 components and all P20 faculty. It will provide the central
mechanism for monitoring progress and evaluating performance of all P20 components. It will provide the
coordinating mechanism between the P20 faculty and the P20 Internal and External Advisory Boards. The
Administrative Core will maintain liaison between the P20, the Case Comprehensive Cancer Center, and the
School of Medicine leadership, as well as with external organizations including NCI, other P20s and the SPORE
community in general. Core responsibilities will include:
• Oversee conduct of all P20 activities;
• Convene monthly meetings of the P20 Executive Committee;
• Coordinate twice yearly progress presentations of all P20 components to the Executive Committee;
• Organize twice yearly meetings and P20 progress reviews by the P20 Internal Advisory Board;
• Organize annual visits and P20 progress reviews by the P20 External Advisory Board;
• Oversee administration, coordination, and quality assessment of all P20 Core Facilities;
• Coordinate all P20 seminars and the P20 annual retreat;
• Organize and coordinate meetings of the P20 Patient Advocacy Board;
• Organize and coordinate meetings of the P20 Community Advisory Board;
• Coordinate solicitation and evaluation of developmental research awards;
• Oversee management and accounting of grant funds; assure monthly reconciliation of all accounts;
• Assure compliance and maintain documents for all institutional regulatory requirements for human
experimentation, animal utilization, toxic material and safety training and utilization;
• Ensure compliance and coordination with all P20 reporting regulations;
• Manage all intellectual property affairs arising from P20-sponsored research;
• Represent the P20 in interactions with other Centers, Departments, and the School of Medicine;
• Coordinate and assure participation of the Case Cancer Disparities P20 in National P20/SPORE meetings.
项目总结/摘要
行政核心将提供癌症病例的总体指导、协调和管理。
第20章.管理核心将包括:P20多名主要研究者(核心合作研究者)
P20行政协调员。行政核心将监督以下机构的运作:
P20执行委员会、P20内部咨询委员会、P20外部咨询委员会、P20
社区咨询委员会和P20患者倡导委员会。它将负责促进,
协调、激励、监测和维护对所有P20活动的科学和财务监督。它将
为所有P20组件和所有P20教师之间的互动提供中心论坛。它将提供中央
监测进展情况和评价P20所有组成部分业绩的机制。其将提供该
P20教师和P20内部和外部咨询委员会之间的协调机制。的
行政核心将保持P20、病例综合癌症中心和
医学院的领导,以及与外部组织,包括NCI,其他P20和SPORE
社区一般。核心职责包括:
·监督所有P20活动的开展;
·每月召开P20执行委员会会议;
·协调每年两次向执行委员会提交所有P20组成部分的进度报告;
·每年组织两次会议,并由P20内部咨询委员会进行P20进展审查;
·组织P20外部咨询委员会的年度访问和P20进展审查;
·监督所有P20核心设施的管理、协调和质量评估;
·协调所有P20研讨会和P20年度务虚会;
·组织和协调P20患者倡导委员会的会议;
·组织和协调P20社区咨询委员会会议;
·协调发展研究奖的征集和评估;
·监督赠款资金的管理和会计;确保每月对所有账户进行对账;
·确保合规性并维护所有机构对人类的监管要求的文件
实验、动物利用、有毒材料和安全培训和利用;
·确保遵守和协调所有P20报告规定;
·管理P20赞助研究产生的所有知识产权事务;
·代表P20与其他中心、部门和医学院进行互动;
·协调并确保癌症差异病例P20参与国家P20/SPORE会议。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Li Li其他文献
N-doped carbon nanotubes synthesized in high yield and decorated with CeO2 and SnO2 nanoparticles
高产率合成并用 CeO2 和 SnO2 纳米粒子装饰的 N 掺杂碳纳米管
- DOI:
10.1016/j.jallcom.2011.06.051 - 发表时间:
2011-09 - 期刊:
- 影响因子:6.2
- 作者:
Li Li;Lei Chen;Guo Zhang;Rui Zhang;Keying Shi - 通讯作者:
Keying Shi
Observer-based preview repetitive control for uncertain discrete-time systems
不确定离散时间系统基于观测器的预览重复控制
- DOI:
10.1002/rnc.5342 - 发表时间:
2020 - 期刊:
- 影响因子:3.9
- 作者:
Li Li - 通讯作者:
Li Li
A new continuous-discrete particle filter for continuous-discrete nonlinear systems
一种用于连续离散非线性系统的新型连续离散粒子滤波器
- DOI:
10.1016/j.ins.2013.04.030 - 发表时间:
2013-09 - 期刊:
- 影响因子:8.1
- 作者:
Xia Yuanqing;Deng Zhihong(邓志红);Li Li;Geng Xiumei - 通讯作者:
Geng Xiumei
Li Li的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Li Li', 18)}}的其他基金
Racial Disparities and Colorectal DNA Methylation- Driven Gene Expression
种族差异和结直肠 DNA 甲基化驱动的基因表达
- 批准号:
10726172 - 财政年份:2023
- 资助金额:
$ 8.4万 - 项目类别:
Unraveling the Locus Coeruleus Circuitry in Opioidinduced Sleep Disturbances
解开阿片类药物引起的睡眠障碍中的蓝斑回路
- 批准号:
10187134 - 财政年份:2021
- 资助金额:
$ 8.4万 - 项目类别:
Strengthening Addiction Care Continuum through Community Consortium in Vietnam
通过越南社区联盟加强成瘾护理连续性
- 批准号:
10668507 - 财政年份:2021
- 资助金额:
$ 8.4万 - 项目类别:
Unraveling the Locus Coeruleus Circuitry in Opioidinduced Sleep Disturbances
解开阿片类药物引起的睡眠障碍中的蓝斑回路
- 批准号:
10832803 - 财政年份:2021
- 资助金额:
$ 8.4万 - 项目类别:
Unraveling the Locus Coeruleus Circuitry in Opioidinduced Sleep Disturbances
解开阿片类药物引起的睡眠障碍中的蓝斑回路
- 批准号:
10375581 - 财政年份:2021
- 资助金额:
$ 8.4万 - 项目类别:
Epigenetic age acceleration, neighborhood disadvantage, and racial disparities in risk of colon adenoma
表观遗传年龄加速、邻里劣势和结肠腺瘤风险的种族差异
- 批准号:
10005929 - 财政年份:2018
- 资助金额:
$ 8.4万 - 项目类别:
Epigenetic age acceleration, neighborhood disadvantage, and racial disparities in risk of colon adenoma
表观遗传年龄加速、邻里劣势和结肠腺瘤风险的种族差异
- 批准号:
10469705 - 财政年份:2018
- 资助金额:
$ 8.4万 - 项目类别:
The immunoregulatory role of Alveolar Macrophages in Chronic Beryllium Disease
肺泡巨噬细胞在慢性铍病中的免疫调节作用
- 批准号:
9176462 - 财政年份:2016
- 资助金额:
$ 8.4万 - 项目类别:
UCLA/Vietnam Training Program in Evaluation and Advanced Methodologies
加州大学洛杉矶分校/越南评估和高级方法培训计划
- 批准号:
9264047 - 财政年份:2016
- 资助金额:
$ 8.4万 - 项目类别:
相似海外基金
Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
- 批准号:
10760051 - 财政年份:2023
- 资助金额:
$ 8.4万 - 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
- 批准号:
2303692 - 财政年份:2023
- 资助金额:
$ 8.4万 - 项目类别:
Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
- 批准号:
468168 - 财政年份:2022
- 资助金额:
$ 8.4万 - 项目类别:
Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10427960 - 财政年份:2022
- 资助金额:
$ 8.4万 - 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
- 批准号:
10577074 - 财政年份:2022
- 资助金额:
$ 8.4万 - 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
- 批准号:
486588 - 财政年份:2022
- 资助金额:
$ 8.4万 - 项目类别:
Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
- 批准号:
2760091 - 财政年份:2022
- 资助金额:
$ 8.4万 - 项目类别:
Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10621188 - 财政年份:2022
- 资助金额:
$ 8.4万 - 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
- 批准号:
10891016 - 财政年份:2021
- 资助金额:
$ 8.4万 - 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
- 批准号:
10230365 - 财政年份:2020
- 资助金额:
$ 8.4万 - 项目类别: